Develops drugs for Parkinson's disease and endocrine disorders.
Jun 2026Revenue $3.12B/yrExpenses $2.66B/yr
No trend
Figures by year
Is Amneal Pharmaceuticals profitable?
Yes. In the 12 months to Jun 2026, revenue was $3.12B and expenses $2.66B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $3.02B | $2.62B | $394M |
| Dec 2024 | $2.79B | $2.54B | $249M |
| Dec 2023 | $2.39B | $2.19B | $204M |
| Dec 2022 | $2.21B | $2.31B | −$94.9M |
| Dec 2021 | $2.09B | $1.94B | $153M |
| Dec 2020 | $1.99B | $1.90B | $91.2M |
| Dec 2019 | $1.63B | $1.88B | −$249M |
| Dec 2018 | $1.66B | $1.68B | −$19.7M |
| Dec 2017 | $1.03B | $789M | $245M |
| Dec 2016 | $1.02B | $733M | $285M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.